Y2Rosuva Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Sungui BioPharm Co., Ltd.
MFDS item code 202106980 · Approved 2021.10.18
Treatment of dyslipidemia; prevention of cardiovascular disease; inhibition of the progression of atherosclerosis
This medication is used as an adjunct for patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are insufficient. It can also be prescribed in conjunction with diet or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. This drug effectively lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis. In particular, it is used as an adjunct to diet for pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, helping to reduce cholesterol levels above specific thresholds. Additionally, it is useful in patients with primary dysbetalipoproteinemia and may be expected to reduce the risk of stroke, myocardial infarction, and arterial revascularization in elderly patients at high risk for cardiovascular disease. Therefore, this medication is used to improve the risks of hypercholesterolemia and related cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response. The dose may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this medicine is contraindicated in some of these patients.
Age 10 years ~ age 17 years: The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy in children under 10 years of age have not been established.
This medication should not be used in certain patients. For example, it is contraindicated for patients who are allergic to any of its components, patients with severe liver impairment, patients with muscle disorders, patients with severe kidney diseases, and women who are pregnant or breastfeeding. This drug may affect liver function, so patients with a history of liver disease or heavy alcohol consumption should use it with caution. It is advisable to undergo regular liver function tests during treatment. Symptoms such as muscle pain or weakness may occur, and rarely, serious muscle damage may arise; therefore, if any such symptoms appear, they should be immediately reported to medical staff. Moreover, muscle-related tests should be performed to check for abnormalities. This medication may interact with other drugs, so if taking other medications, patients must inform their healthcare provider. Caution is especially needed when used concurrently with certain antibiotics, antifungals, immunosuppressants, or fibrates. Women of childbearing potential should use proper contraceptive methods while taking this medication, and if pregnancy is confirmed, they must stop taking it immediately. In the case of overdose, since there is no specific antidote, symptomatic treatment should be administered, and liver function and muscle enzyme levels should be monitored. This medication may rarely cause serious skin reactions or liver dysfunction; therefore, if symptoms like skin rash, jaundice, or severe fatigue occur, patients should consult with healthcare professionals immediately. Dizziness may occur during driving or operating machinery, so caution is required. When used in children and adolescents, careful monitoring of growth and development is essential.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle, 30 tablets/box [15 tablets/PTP (Alu-Alu) x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Sungui BioPharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.